These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 63805)

  • 1. Prognostic significance of lymphocyte surface markers in adult non-Hodgkin's malignant lymphoma.
    Bloomfield CD; Kersey JH; Brunning RD; Gajl-Peczalska KJ
    Lancet; 1976 Dec; 2(7999):1330-3. PubMed ID: 63805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of lymphocytic surface markers and histology in adult non-Hodgkin's lymphoma.
    Bloomfield CD; Kersey JH; Brunning RD; Gajl-Peczalska KJ
    Cancer Treat Rep; 1977 Sep; 61(6):963-70. PubMed ID: 332359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface markers and functional properties of non-Hodgkin's lymphoma cells in relation to histology.
    Bom-Van Noorloos AA; Splinter TA; van Heerde P; van Beek AA; Melief CJ
    Cancer; 1978 Oct; 42(4):1804-17. PubMed ID: 152144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.
    Pinkus GS; Said JW
    Am J Pathol; 1979 Feb; 94(2):349-80. PubMed ID: 311589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of lymphocyte surface markers combined with the Lukes-Collins histologic classification in adult lymphoma.
    Bloomfield CD; Gajl-Peczalska KJ; Frizzera G; Kersey JH; Goldman AI
    N Engl J Med; 1979 Sep; 301(10):512-8. PubMed ID: 313510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and prognostic significance of the T-B immunological classification of non-Hodgkin's lymphomas.
    Ogasawara H; Fujitani T; Mizojiri G; Hattori H
    Laryngoscope; 1981 Jan; 91(1):125-32. PubMed ID: 7005580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.
    Habeshaw JA; Catley PF; Stansfeld AG; Brearley RL
    Br J Cancer; 1979 Jul; 40(1):11-34. PubMed ID: 314300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etiological, clinical and prognostic significance of the T-B immunological classification of primary acute lymphoid leukemias and non Hodgkin's lymphomas.
    Belpomme D; Lelarge N; Mathé G; Davies AJ
    Haematol Blood Transfus; 1977; 20():33-45. PubMed ID: 305400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface markers in non-Hodgkin's lymphomas.
    Rudders RA
    Hosp Pract (Off Ed); 1983 Jan; 18(1):161-4, 169-70, 172 passim. PubMed ID: 6401266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic and cytochemical cell markers in non-Hodgkin's lymphomas.
    Davey FR; Goldberg J; Stockman J; Gottlieb AJ
    Lab Invest; 1976 Nov; 35(5):430-8. PubMed ID: 792563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte surface characteristics in malignant lymphoma.
    Aisenberg AC; Long JC
    Am J Med; 1975 Mar; 58(3):300-6. PubMed ID: 1090157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of surface receptors with histological appearance in 29 cases of non-Hodgkin lymphoma.
    Habeshaw JA; Macaulay RA; Stuart AE
    Br J Cancer; 1977 Jun; 35(6):858-67. PubMed ID: 301396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological markers in non-Hodgkin's lymphomas.
    Gobbi M; Mazza P; Mantovani W; Fiacchini M; Lauria F; Tura S
    Boll Ist Sieroter Milan; 1979 Nov; 58(5):410-5. PubMed ID: 399843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Description of the cells from the lymph nodes of patients with non-Hodgkin's lymphoma according to some B- and T-cell characteristics.
    Stathopoulos G; Papamichail M; Holborow EJ; Davies AJ
    Br J Exp Pathol; 1977 Feb; 58(1):95-100. PubMed ID: 300026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of surface markers in non-Hodgkin's lymphoma by using anti-T and anti-B lymphocyte sera.
    Yamanaka N; Ishii Y; Koshiba H; Mikuni C; Ogasawara M; Kikuchi K
    Cancer; 1981 Jan; 47(2):311-8. PubMed ID: 7006795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nodular lymphocyte predominance type of Hodgkin's disease is a B cell lymphoma.
    Poppema S; Timens W; Visser L
    Adv Exp Med Biol; 1985; 186():963-9. PubMed ID: 2931963
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunologic abnormalities in patients with malignant lymphoproliferative diseases.
    Hunter CP; Tannenbaum H; Churchill WH; Moloney WC; Schur PH
    J Natl Cancer Inst; 1977 May; 58(5):1185-90. PubMed ID: 323504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Hodgkin's lymphomas. Analysis of 92 cases using the 'international' classification.
    Bain GO
    Arch Pathol Lab Med; 1983 Feb; 107(2):64-9. PubMed ID: 6600607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic surface markers in non-Hodgkin's lymphomas.
    Cossman J; Schnitzer B; Deegan MJ
    Am J Pathol; 1977 Apr; 87(1):19-32. PubMed ID: 322504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic aspects and pathology of the malignant lymphomas.
    Berard CW; Jaffe ES; Braylan RC; Mann RB; Nanba K
    Cancer; 1978 Aug; 42(2 Suppl):911-21. PubMed ID: 356957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.